CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells

Loading...
Thumbnail Image
Files
eaaz0571.full.pdf(1.6 MB)
Published Version
aaz0571_SM.pdf(1.52 MB)
Supplementary Materials
Date
2020-05-06
Authors
Goodwin, M.
Lee, E.
Lakshmanan, U.
Shipp, S.
Froessl, L.
Barzaghi, F.
Passerini, L.
Narula, M.
Sheikali, A.
Lee, Ciaran M.
Journal Title
Journal ISSN
Volume Title
Publisher
American Association for the Advancement of Science
Published Version
Research Projects
Organizational Units
Journal Issue
Abstract
The prototypical genetic autoimmune disease is immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome, a severe pediatric disease with limited treatment options. IPEX syndrome is caused by mutations in the forkhead box protein 3 (FOXP3) gene, which plays a critical role in immune regulation. As a monogenic disease, IPEX is an ideal candidate for a therapeutic approach in which autologous hematopoietic stem and progenitor (HSPC) cells or T cells are gene edited ex vivo and reinfused. Here, we describe a CRISPR-based gene correction permitting regulated expression of FOXP3 protein. We demonstrate that gene editing preserves HSPC differentiation potential, and that edited regulatory and effector T cells maintain their in vitro phenotype and function. Additionally, we show that this strategy is suitable for IPEX patient cells with diverse mutations. These results demonstrate the feasibility of gene correction, which will be instrumental for the development of therapeutic approaches for other genetic autoimmune diseases.
Description
Keywords
IPEX syndrome , Forkhead box protein 3 gene , FOXP3 , Immune regulation , Gene correction
Citation
Goodwin, M., Lee, E., Lakshmanan, U., Shipp, S., Froessl, L., Barzaghi, F., Passerini, L., Narula, M., Sheikali, A., Lee, C. M., Bao, G., Bauer, C. S., Miller, H. K., Garcia-Lloret, M., Butte, M. J., Bertaina, A., Shah, A., Pavel-Dinu, M., Hendel, A., Porteus, M., Roncarolo, M. G. and Bacchetta, R. (2020) 'CRISPR-based gene editing enables FOXP3 gene repair in IPEX patient cells', Science Advances, 6(19), eaaz0571 (17pp). doi: 10.1126/sciadv.aaz0571